Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
SMAD1 Antibody
NCTP01316
Description: Rabbit polyclonal to human SMAD1
Application: ELISA, WB, IHC
Reactivity: Human, mouse, rat
Catalog #: NCTP01316
$380
1000 Items
Overview
| DESCRIPTION | |
| Species Reactivity | Human, mouse, rat. Other species not tested. |
| Isotype | IgG |
| Immunogen | A peptide near the C terminal of human SMAD1 |
| Accession # | Q15797 |
| Alternative Names | Mothers against decapentaplegic homolog 1; MAD homolog 1; Mothers against DPP homolog 1; JV4-1; Mad-related protein 1; Smad1; hSMAD1; BSP-1; BSP1; MADH1; MADR1 |
| Purification | Purified by peptide affinity column. |
| Formulation | Lyophilized with 1% BSA and 0.02% NaN3. |
| Size | 100µg/200µl |
| APPLICATION | |
| ELISA | 1:1000-1:10000 |
| Western Blot | 1:200-1:1,000 |
| Immunohistochemistry | 1:200-1:500 |
| - | For research use only. Optimal dilutions/concentrations should be determined by each laboratory for each application. |
| PREPARATION AND STORAGE | |
| Reconstitution | Reconstitute in 200µl of sterile H2O. |
| Storage | Shipped at ambient temperature. Store immediately at -20°C upon receipt. Avoid repeated freeze-thaw cycles. |
| REFERENCES | |
| - | Pannu, J., Asano, Y., Nakerakanti, S., et al. Smad1 pathway is activated in systemic sclerosis fibroblasts and is targeted by imatinib mesylate. Arthritis Rheum. 58 (8), 2528-2537 (2008). |